Core C provides a critical means by which the PPG will achieve its goals of understanding the in vivo functions of pathways in the B7:CD28 family individually, the interactions among these pathways, and their roles in regulating the balance between pathogenic and protective T cells in lymphoid and non-lymphoid organs. This Core will provide PPG investigators with an important and unique collection of mouse strains for the analysis of pathways in the B7:CD28 family in vivo and has the expertise with both conventional and conditional transgenic and knockout technology that will enable the generation of novel mouse strains for analyzing the functions of these pathways in vivo.
Our specific aims are: 1) To generate novel mouse strains lacking CD28 or B7 family members, conditionally or inducibly, 2) To generate transgenic strains that overexpress B7:CD28 family members, either constitutively or inducibly 3) To generate mouse strains that facilitate the analysis of interactions between negative regulatory receptors or the interplay between positive and negative second signals in the B7:CD28 family, 4) To generate mouse strains that facilitate the analysis of roles of B7:CD28 family members in regulating the balance between protective and pathogenic immune responses by breeding mice lacking or overexpressing B7 or CD28 family members with cytokine, cytokine receptor, and FoxP3 reporter strains, and 5) To maintain and provide mice of existing transgenic and knockout strains to PPG investigators. Core C will work closely with project investigators, not only to provide them with transgenic and knockout strains, but also to generate novel strains based upon their findings in PPG projects. Core C also will provide mice lacking B7 and CD28 family members to Core B for the generation of novel mAbs and transgenic mice for studies aimed at evaluating agonistic Ig fusion proteins and mAbs that deliver a negative signal. Taken together, these activities of Core C will provide PPG investigators with novel mouse strains for studying the roles of pathways in the B7:CD28 family in controlling T cell responses in mouse models of transplantation, autoimmunity, and infection. These studies will not only provide insights into the roles of these pathways in regulating T cell activation and tolerance in vivo, but also may provide information critical for therapeutic manipulation of these key immunoregulatory pathways.
These studies will provide the basis for understanding how, where and when costimulatory molecules regulate allograft rejection, organ-specific autoimmune diseases, and chronic viral infection These studies have implications for developing costimulation-based therapies for human chronic viral infections, cancer, autoimmune diseases and alloresponses that limit hematopoietic and solid organ allograft acceptance.
| Dixon, Karen O; Schorer, Michelle; Nevin, James et al. (2018) Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. J Immunol 200:3000-3007 |
| Fan, Martin Y; Turka, Laurence A (2018) Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells. Front Immunol 9:69 |
| Wu, Chuan; Chen, Zuojia; Xiao, Sheng et al. (2018) SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells. Cell Rep 22:653-665 |
| Juchem, Kathryn W; Sacirbegovic, Faruk; Zhang, Cuiling et al. (2018) PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease. J Immunol 200:834-846 |
| Priyadharshini, Bhavana; Loschi, Michael; Newton, Ryan H et al. (2018) Cutting Edge: TGF-? and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets. J Immunol 201:2215-2219 |
| Porichis, Filippos; Hart, Meghan G; Massa, Alexandra et al. (2018) Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells. J Immunol 201:971-981 |
| LaFleur, Martin W; Muroyama, Yuki; Drake, Charles G et al. (2018) Inhibitors of the PD-1 Pathway in Tumor Therapy. J Immunol 200:375-383 |
| Chaudhri, Apoorvi; Xiao, Yanping; Klee, Alyssa N et al. (2018) PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface. Cancer Immunol Res 6:921-929 |
| Ahn, Eunseon; Araki, Koichi; Hashimoto, Masao et al. (2018) Role of PD-1 during effector CD8 T cell differentiation. Proc Natl Acad Sci U S A 115:4749-4754 |
| Wu, Yongxia; Schutt, Steven; Paz, Katelyn et al. (2018) MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice. Blood 131:1974-1986 |
Showing the most recent 10 out of 332 publications
